Back
Neurocrine Biosciences, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
60
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$135.82
Seasonality Move:
-2.87%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Neurocrine Biosciences, Inc. Stock Forecast
-
Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 27.1% based on the past 29 years of stock performance.
-
Neurocrine Biosciences, Inc. has risen higher in 18 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.07%
-
Is Neurocrine Biosciences, Inc. Stock Undervalued?The current Neurocrine Biosciences, Inc. [NBIX] share price is $137.37. The Score for NBIX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 27.1% based on the past 29 years of stock performance.
Neurocrine Biosciences, Inc. Stock Rating
Buy
60
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. overpriced?
-
Neurocrine Biosciences, Inc. has risen higher in 18 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.07%
Neurocrine Biosciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
160.18
52-Week Low:
84.23
Prediction Charts
Market Cap:
13.7B
Price in USD:
137.37
Volume:
800.6K
Beta:
0.78
Technical Analysis
SMA50:
144.10
SMA100:
143.06
SMA200:
132.70
52-Wk Change:
-6.4%
Stock Predictions
-
Is Neurocrine Biosciences, Inc. stock public?Yes, Neurocrine Biosciences, Inc. is a publicly traded company.
-
What is the Neurocrine Biosciences, Inc. stock quote today?The Neurocrine Biosciences, Inc. stock price is 137.37 USD today.
-
How to buy Neurocrine Biosciences, Inc. stock online?You can buy Neurocrine Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 141.59 | 140.60 | 142.07 | 138.64 |
| Jan-5 | 136.00 | 135.99 | 138.18 | 134.03 |
| Jan-6 | 136.77 | 137.35 | 138.53 | 135.95 |
| Jan-7 | 138.03 | 140.62 | 142.16 | 137.60 |
| Jan-8 | 139.54 | 135.57 | 139.68 | 134.20 |
| Jan-9 | 135.99 | 135.79 | 137.08 | 134.87 |
| Jan-12 | 135.21 | 132.66 | 135.55 | 132.16 |
| Jan-13 | 133.20 | 132.26 | 133.78 | 131.33 |
| Jan-14 | 132.17 | 135.33 | 135.48 | 132.01 |
| Jan-15 | 135.24 | 133.35 | 135.98 | 131.30 |
| Jan-16 | 133.31 | 132.39 | 134.02 | 131.36 |
| Jan-20 | 130.22 | 134.54 | 134.77 | 129.17 |
| Jan-21 | 135.34 | 135.41 | 136.19 | 133.72 |
| Jan-22 | 135.57 | 137.37 | 137.73 | 134.94 |
Neurocrine Biosciences, Inc. Earnings
Neurocrine Biosciences, Inc. Earnings Report: Per Share Neurocrine Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences, Inc. Forecast Revenue Growth
Neurocrine Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.25 per share, and an increase next year of $1.35 per share.
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.